ALVO

Handel nachbörslich: 4.86 0.01 +0.21%

Alvotech (ALVO)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Alvotech Stock (ALVO) Company Profile

Healthcare (1108)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ALVO's Discussions on Twitter

Compare ALVO vs TAK, ZTS, HLN, TEVA, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALVO Alvotech	4.85	1.62B	391.87M	-441.45M	-301.21M	-1.85
TAK Takeda Pharmaceutical Co Adr	18.28	57.18B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	128.67	56.47B	9.40B	2.65B	2.24B	5.935
HLN Haleon Plc Adr	11.16	49.16B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	34.31	40.03B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	475.85	20.37B	3.13B	1.27B	1.12B	26.39

Alvotech Stock (ALVO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Underweight
2025-11-04	Herabstufung	Deutsche Bank	Buy → Hold
2025-10-14	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2025-09-23	Hochstufung	Deutsche Bank	Hold → Buy
2025-02-14	Eingeleitet	UBS	Buy
2024-01-29	Hochstufung	Barclays	Equal Weight → Overweight
2023-10-20	Hochstufung	Citigroup	Sell → Neutral
2023-09-21	Eingeleitet	Barclays	Equal Weight
2022-09-07	Eingeleitet	Morgan Stanley	Equal-Weight
2022-09-06	Herabstufung	Citigroup	Buy → Sell
2022-07-26	Eingeleitet	Citigroup	Buy

Alle ansehen

Alvotech Aktie (ALVO) Neueste Nachrichten

Finanzdaten der Alvotech-Aktie (ALVO)

Alvotech (ALVO)

Alvotech Stock (ALVO) Company Profile

Compare ALVO vs TAK, ZTS, HLN, TEVA, UTHR

Alvotech Stock (ALVO) Upgrades & Downgrades

Alvotech Aktie (ALVO) Neueste Nachrichten

Assessing Alvotech (ALVO) Valuation After AVT80 Trial Success And New Sandoz Agreements - simplywall.st

Alvotech Increases Share Capital by $125,000 Through Issuance of 12.5 Million Ordinary Shares - Quiver Quantitative

Alvotech Announces Increase in Number of Own Shares - Chartmill

Alvotech (ALVO) Investor Outlook: Exploring a 331% Potential Upside in the Biosimilars Market - DirectorsTalk Interviews

ALVO INVESTOR ALERT: Hagens Berman Investigates Alvotech - GlobeNewswire

Press releases provided by CNW - Techaeris

Aug Drivers: What is the Moat Score of Alvotech Equity WarrantQuarterly Trade Review & Weekly Setup with ROI Potential - baoquankhu1.vn

Alvotech Faces Securities Claims Investigation - Intellectia AI

Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - morningstar.com

Are Expanded Sandoz Biosimilar Deals Quietly Reframing Alvotech’s Partnership Strategy and Scale Ambitions (ALVO)? - simplywall.st

Alvotech higher on positive data backing biosimilar to Takeda’s Entyvio - MSN

Positive PK Results Put Alvotech’s Vedolizumab Biosimilar On Path Toward Filings - Citeline News & Insights

ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire

Private Equity Firms Are Alvotech's (NASDAQ:ALVO) Biggest Owners and Were Hit After Market Cap Dropped US$63m - 富途牛牛

Alvotech Hits Pivotal Milestone With Positive PK Data for Entyvio Biosimilar AVT80 - TipRanks

Alvotech (NASDAQ: ALVO) posts positive pivotal data for Entyvio biosimilar - Stock Titan

Alvotech Reports Positive Top-line Pharmacokinetic Study Results For AVT80, A Biosimilar To Entyvio - Nasdaq

Why Is ALVO Stock Rising Pre-Market Today? - Stocktwits

Alvotech (NASDAQ:ALVO) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Alvotech Reports Positive Results for AVT80 Clinical Study - Intellectia AI

Fuji Pharma Lifts Sales Outlook but Slashes Profit Forecast on Alvotech Valuation Loss - TipRanks

Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio® - The Manila Times

Alvotech Announces Positive Top-Line Results from AVT80 Pharmacokinetic Study Compared to Entyvio® - Quiver Quantitative

Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio - marketscreener.com

ROSEN, A LEADING NATIONAL FIRM, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - marketscreener.com

Alvotech (ALVO): A bull case theory - MSN

Alvotech (ALVO): A Bull Case Theory - Insider Monkey

Alvotech (ALVO) Growth Potential: A Deep Dive into Its 316.67% Upside and Biosimilar Innovations - DirectorsTalk Interviews

Is It Time To Reconsider Alvotech (ALVO) After Its Sharp Three-Year Share Price Slide? - simplywall.st

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - TMX Newsfile

Assessing Alvotech (ALVO) Valuation After Mixed Short Term Gains And A Steep One Year Decline - Yahoo Finance

Alvotech appoints Lisa Graver as CEO - Pharmafile

Chipmakers Recap: How does Alvotech score in quality rankingsMarket Performance Summary & Free Verified High Yield Trade Plans - baoquankhu1.vn

Alvotech (NASDAQ:ALVO) Trading Down 0.9%Should You Sell? - MarketBeat

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bluefield Daily Telegraph

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates - wahanariau.com

Alvotech’s Volatile Climb: Can A High?Beta Biosimilar Pure?Play Win Back Investor Trust? - AD HOC NEWS

Death Cross: Is Alvotech stock overvalued or fairly pricedMarket Movers & Verified Momentum Stock Alerts - baoquankhu1.vn

Alvotech Hooks Up With Sandoz For Biosimilars In Canada, Australia And New Zealand - Citeline News & Insights

Alvotech Strikes Sandoz Biosimilar Supply and Commercialization Deals in Canada, Australia and New Zealand - TipRanks

Alvotech (NASDAQ: ALVO) inks Sandoz biosimilar pacts for Canada, Australia and New Zealand - Stock Titan

Alvotech Signs Biosimilar Supply, Commercialization Deals with Switzerland's Sandoz - marketscreener.com

Alvotech Enters Supply, Commercialization Deal With Sandoz Covering Biosimilar Candidates - Nasdaq

Alvotech Enters Supply Agreements with Sandoz for Biosimilars - intellectia.ai

Alvotech Enters Supply and Commercialization Agreements with Sandoz for Multiple Biosimilar Candidates in Canada, Australia, and New Zealand - Quiver Quantitative

Bond Watch: What is the Moat Score of Alvotech Equity Warrant2025 Trading Volume Trends & Weekly Sector Rotation Insights - baoquankhu1.vn

Aug Levels: Is Alvotech stock showing strong momentum2025 Performance Recap & Low Drawdown Momentum Ideas - baoquankhu1.vn

How Investors May Respond To Alvotech (ALVO) Securing Global Rights For Its Eylea Biosimilar Launch - Sahm

Alvotech resolves global patent disputes with Regeneron and Bayer over Eylea biosimilar - MSN

(ALVO) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Finanzdaten der Alvotech-Aktie (ALVO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie ALVO